These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 6231575)
1. [Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol]. Deméocq F; Carton P; Patte C; Oberlin O; Sarrazin D; Lemerle J Presse Med; 1984 Mar; 13(12):717-21. PubMed ID: 6231575 [TBL] [Abstract][Full Text] [Related]
2. Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP). Deméocq F; Oberlin O; Benz-Lemoine E; Boilletot A; Gentet JC; Zucker JM; Behar C; Poutard P; Olive D; Brunat-Mentigny M Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S45-7. PubMed ID: 2667789 [TBL] [Abstract][Full Text] [Related]
3. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
4. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies. Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301 [TBL] [Abstract][Full Text] [Related]
6. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153 [TBL] [Abstract][Full Text] [Related]
7. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
8. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058 [TBL] [Abstract][Full Text] [Related]
9. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies. Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366 [TBL] [Abstract][Full Text] [Related]
14. The response of Ewing's sarcoma to sequential cyclophosphamide and adriamycin induction therapy. Hayes FA; Thompson EI; Hustu HO; Kumar M; Coburn T; Webber B J Clin Oncol; 1983 Jan; 1(1):45-51. PubMed ID: 6668483 [TBL] [Abstract][Full Text] [Related]
15. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Oberlin O; Patte C; Demeocq F; Lacombe MJ; Brunat-Mentigny M; Demaille MC; Tron P; N'Guyen Bui B; Lemerle J Eur J Cancer Clin Oncol; 1985 Apr; 21(4):463-7. PubMed ID: 3839188 [TBL] [Abstract][Full Text] [Related]
16. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Craft AW; Cotterill SJ; Bullimore JA; Pearson D Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188 [TBL] [Abstract][Full Text] [Related]
17. The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study. Perez CA; Tefft M; Nesbit M; Burgert EO; Vietti T; Kissane J; Pritchard DJ; Gehan EA Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):141-9. PubMed ID: 7012102 [No Abstract] [Full Text] [Related]
18. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide]. Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734 [TBL] [Abstract][Full Text] [Related]
19. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014 [TBL] [Abstract][Full Text] [Related]